These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27234486)

  • 1. Prediction for Improvement of Liver Function after Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices to Manage Portosystemic Shunt Syndrome.
    Yamamoto A; Nishida N; Morikawa H; Jogo A; Kageyama K; Sohgawa E; Hamamoto S; Takeshita T; Sakai Y; Matsuoka T; Kawada N; Miki Y
    J Vasc Interv Radiol; 2016 Aug; 27(8):1160-7. PubMed ID: 27234486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores.
    Saad WE; Wagner CC; Al-Osaimi A; Bliebel W; Lippert A; Davies MG; Sabri SS; Turba UC; Matsumoto AH; Angle JF; Caldwell S
    Vasc Endovascular Surg; 2013 May; 47(4):281-7. PubMed ID: 23681780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices.
    Choi YS; Lee JH; Sinn DH; Song YB; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC
    J Clin Gastroenterol; 2008 Oct; 42(9):974-9. PubMed ID: 18528292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration.
    Shinkai K; Sakamori R; Yamada R; Tahata Y; Nozaki Y; Matsumoto K; Tawara S; Fukuda K; Yoshida Y; Tanaka S; Ito T; Doi Y; Iio S; Sakakibara M; Nakanishi F; Kodama T; Hikita H; Tatsumi T; Takehara T
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1148-1155. PubMed ID: 35430734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study.
    Jang SY; Kim GH; Park SY; Cho CM; Tak WY; Kim JH; Choe WH; Kwon SY; Lee JM; Kim SG; Kim DY; Kim YS; Lee SO; Min YW; Lee JH; Paik SW; Yoo BC; Lim JW; Kim HJ; Cho YK; Sohn JH; Jeong JY; Lee YH; Kim TY; Kweon YO
    Clin Mol Hepatol; 2012 Dec; 18(4):368-74. PubMed ID: 23323252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices.
    Kim SK; Lee KA; Sauk S; Korenblat K
    Korean J Radiol; 2017; 18(2):345-354. PubMed ID: 28246514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balloon-occluded retrograde transvenous obliteration for intractable gastric variceal bleeding.
    Liang TJ; Chen YC; Liang HL; Liu SI; Chang PM
    J Formos Med Assoc; 2013 Jul; 112(7):426-9. PubMed ID: 23927983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices.
    Shirane Y; Murakami E; Imamura M; Kosaka M; Johira Y; Miura R; Murakami S; Yano S; Amioka K; Naruto K; Ando Y; Uchikawa S; Teraoka Y; Uchida T; Fujino H; Ono A; Nakahara T; Kawaoka T; Miki D; Yamauchi M; Okamoto W; Tsuge M; Chosa K; Awai K; Aikata H; Oka S
    BMC Gastroenterol; 2022 Dec; 22(1):535. PubMed ID: 36550416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution.
    Oshita K; Ohira M; Honmyo N; Kobayashi T; Murakami E; Aikata H; Baba Y; Kawano R; Awai K; Chayama K; Ohdan H
    J Gastroenterol; 2020 Sep; 55(9):877-887. PubMed ID: 32533300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in portal systemic pressure gradient after balloon-occluded retrograde transvenous obliteration of gastric varices and aggravation of esophageal varices.
    Tanihata H; Minamiguchi H; Sato M; Kawai N; Sonomura T; Takasaka I; Nakai M; Sahara S; Nakata K; Shirai S
    Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1209-16. PubMed ID: 19688368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts.
    Ishikawa T; Aibe Y; Matsuda T; Iwamoto T; Takami T; Sakaida I
    AJR Am J Roentgenol; 2017 Sep; 209(3):W169-W176. PubMed ID: 28657848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing logistics for balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices by doing away with the indwelling balloon: concept and techniques.
    Saad WE; Nicholson DB
    Tech Vasc Interv Radiol; 2013 Jun; 16(2):152-7. PubMed ID: 23830672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balloon Retrograde Transvenous Obliteration Versus Endoscopic Cyanoacrylate in Bleeding Gastric Varices: Comparison of Rebleeding and Mortality with Extended Follow-up.
    Stein DJ; Salinas C; Sabri S; Onyeali R; Caldwell S; Henry Z
    J Vasc Interv Radiol; 2019 Feb; 30(2):187-194. PubMed ID: 30717949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory effects of balloon occluded retrograde transvenous obliteration of gastric varices: a prospective controlled study.
    Arai H; Abe T; Takayama H; Toyoda M; Mori K; Ueno T; Takagi H; Shimoda R
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1389-94. PubMed ID: 21443664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver and spleen stiffness on ultrasound elastography are predictors of the occurrence of esophagogastric varices after balloon-occluded retrograde transvenous obliteration.
    Furuichi Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
    J Hepatobiliary Pancreat Sci; 2022 Jun; 29(6):713-722. PubMed ID: 35301809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient.
    Uehara H; Akahoshi T; Tomikawa M; Kinjo N; Hashimoto N; Nagao Y; Kamori M; Maehara Y
    J Gastroenterol Hepatol; 2012 Jan; 27(1):137-41. PubMed ID: 21722180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration.
    Hong CH; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Hong HP; Shin JH
    J Gastroenterol Hepatol; 2009 Mar; 24(3):372-8. PubMed ID: 19032446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon dioxide (CO2) vs iodinated contrast digital subtraction angiography during balloon-occluded retrograde transvenous obliteration (BRTO) using foam sclerosant for gastric varices.
    Koizumi J; Hashimoto T; Myojin K; Itou C; Hara T; Sekiguchi T; Ichikawa T; Imai Y; Kagawa T; Nagata N; Watanabe N; Mine T; Nishibe T; Saguchi T; Janne d'Othée B
    J Vasc Interv Radiol; 2012 Nov; 23(11):1453-1459.e1. PubMed ID: 23101917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.